Skip to content

LSD: all studies

Page 135 of 282: studies 1,341 to 1,350 of 2,816, newest first. Back to the LSD overview

Research

The behavioral pharmacology of hallucinogens.

Biochemical Pharmacology July 20, 2007 William E Fantegrossi, Kevin S. Murnane, Chad J Reissig

Until very recently, comparatively few scientists were studying hallucinogenic drugs. Nevertheless, selective antagonists are available for relevant serotonergic receptors, the majority of which have now been cloned, allowing for reasonably thorough pharmacological investigation. Animal models sensitive to the behavioral effects of the hallucinogens have been established and exploited....

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis

Journal of Psychopharmacology May 1, 2007 Karsten Heekeren, Anna Neukirch, Jörg Daumann et al. 49 citations

Patients with schizophrenia exhibit diminished prepuLse inhibition (PPI) of the acoustic startle reflex and deficits in the attentional moduLation of PPI. Pharmacological challenges with hallucinogens are used as models for psychosis in both humans and animals. RemarkabLy, in contrast to the findings in schizophrenic patients and in animal hallucinogen modeLs of psychosis, previous studies with...

1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.

Journal of Medicinal Chemistry September 21, 2006 Thomas H. Mclean, Jason C. Parrish, Michael R Braden et al. 115 citations

A series of conformationally restricted analogues of the hallucinogenic phenethylamine 1 (2,5-dimethoxy-4-bromophenethylamine, 2C-B) was synthesized to test several hypotheses concerning the bioactive conformation of phenethylamine ligands upon binding to the 5-HT(2A) receptor. These benzocycloalkane analogues were assayed for their receptor binding affinity and ability to activate downstream...

DOI: 10.1021/jm060656o (opens in new tab) Full text (opens in new tab) LSD Psychopharmacology: neuropharmacology Drug action Brain chemistry +15

[Salvia divinorum--representation of a new drug in the Internet].

Das Gesundheitswesen May 1, 2006 Holger Siemann, Michael Specka, Fabrizio Schifano et al. 10 citations

The German pages of the Internet were searched for the presence of the hallucinogenic herbal drug Salvia divinorum, which is not dealt with in current addiction medicine or psychiatric text books. The investigation is part of the EU sponsored project "Psychonaut" as preparatory work for the development of an Internet-based early warning system. The first 100 websites of the search using "Salvia...

Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis

Pharmacopsychiatry September 1, 2005 Euphrosyne Gouzoulis‐mayfrank, Anna Neukirch, Karsten Heekeren 2 citations

Pharmacological challenges with hallucinogens are used as models for psychosis in experimental research. The state induced by glutamate antagonists such as phencyclidine (PCP) is often considered as a more appropriate model of psychosis than the state induced by serotonergic hallucinogens such as lysergic acid (LSD), psilocybin and dimethyltryptamine (DMT). However, so far, this question has...

Can psychedelics have a role in psychiatry once again?

The British Journal of Psychiatry June 1, 2005 Ben Sessa 97 citations

Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3, 4, 5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3, 4-methylenedioxymethamph-etamine (MDMA), N, N-dimethyltrypta-mine (DMT) and their relations occur in abundance throughout the natural world, and have been used by humankind for thousands of years.

Ocular sequelae from the illicit use of class A drugs

British and Irish Orthoptic Journal 2004 Alison Firth 13 citations

Aim: To highlight the changes that may take place in the visual system of the class A drug abuser.Methods: A literature review was carried out of ocular/visual sequelae of the more common class A drugs. These include stimulants (cocaine and crack cocaine), narcotics (heroin, morphine, methadone) and hallucinogenics (ecstasy, lysergic acid diethylamide, magic mushrooms, mescaline,...

Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

Journal of Neuroscience October 1, 2003 Javier González-Maeso, Tony Yuen, Barbara J. Ebersole et al. 295 citations

Most neuropharmacological agents and many drugs of abuse modulate the activity of heptahelical G-protein-coupled receptors. Although the effects of these ligands result from changes in cellular signaling, their neurobehavioral activity may not correlate with results of in vitro signal transduction assays. 5-Hydroxytryptamine 2A receptor (5-HT2AR) partial agonists that have similar...

Drugs of Abuse Monitoring in Blood for Control of Driving Under the Influence of Drugs

Therapeutic Drug Monitoring April 1, 2002 Manfred R. Moeller, Thomas Kræmer 98 citations

Driving under the influence of drugs is an issue of growing concern in the industrialized countries as a risk and a cause for road accidents. In forensic toxicology, the increasing number of samples for determination of drugs in blood is mainly due to zero-tolerance laws in several countries and well-trained police officers who can better recognize drivers under the influence of drugs of abuse....

Effects of the Hallucinogen Psilocybin on Covert Orienting of Visual Attention in Humans

Neuropsychobiology 2002 Euphrosyne Gouzoulis‐mayfrank, B. Thelen, Stefanie Maier et al. 69 citations

Hallucinogenic drug-induced states are considered as models for acute schizophrenic disorders (experimental psychoses). In a double-blind study with healthy volunteers we investigated the influence of the serotonergic hallucinogen psilocybin, the ecstasy-like drug 3,4-methylenedioxyethylamphetamine (MDE), the stimulant d- methamphetamine and placebo on covert orienting of spatial attention (n =...